Vanguard Group Inc Abb Vie Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 170,376,746 shares of ABBV stock, worth $28.4 Billion. This represents 0.62% of its overall portfolio holdings.

Number of Shares

170,376,746

Previous 160,398,331 6.22%

Holding current value

$28.4 Billion

Previous $24.9 Billion 24.82%

% of portfolio

0.62%

Previous 0.55%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $1.59 Billion - $1.82 Billion	9,978,415 Added 6.22%	170,376,746 $31 Billion
Q4 2023 Mar 11, 2024	BUY	$137.6 - $154.97 $6,880 - $7,748	50 Added 0.0%	160,398,331 $24.9 Billion
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $48 Million - $54.1 Million	-349,074 Reduced 0.22%	160,398,281 $24.9 Billion
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $194 Million - $224 Million	1,450,089 Added 0.91%	160,747,355 $24 Billion
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $155 Million - $193 Million	-1,169,081 Reduced 0.73%	159,297,266 $21.5 Billion

Q1 2023 Jul 14, 2023	BUY	$144.61 - $166.54 $2.78 Million - $3.21 Million	19,254 Added 0.01%	160,466,347 $25.6 Billion
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $308 Million - $355 Million	2,129,541 Added 1.35%	160,447,093 $25.6 Billion
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $317 Million - $381 Million	2,295,138 Added 1.47%	158,317,552 $25.6 Billion
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $328 Million - $376 Million	2,442,663 Added 1.59%	156,022,414 $20.9 Billion
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $421 Million - $536 Million	3,060,971 Added 2.03%	153,579,751 $23.5 Billion
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $555 Million - $689 Million	4,206,711 Added 2.88%	150,518,780 $24.4 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $84.1 Million - $106 Million	782,554 Added 0.54%	146,312,069 $19.8 Billion
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $88.9 Million - $101 Million	835,949 Added 0.58%	145,529,515 $15.7 Billion
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $15.2 Billion - $17 Billion	144,693,566 New	144,693,566 $16.3 Billion

Others Institutions Holding ABBV

# of Institutions

3,641

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Abb Vie Inc. Transaction History